Gastrointestinal Therapeutics and Diagnostics Technologies and Global Markets Report 2024-2028: Growing Trend toward Screening and Preventive Care and Adoption and Approval of Biological Drugs - ResearchAndMarkets.com

The "Gastrointestinal Therapeutics and Diagnostics: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

The Global Gastrointestinal Therapeutics and Diagnostics Market was valued at USD 86 Billion in 2023, and is expected to reach USD 122.5 Billion by 2028, rising at a CAGR of 7.30%.

This research study analyzes the GI diagnostics and therapeutics market, offers revenue forecasts, assesses future trends and provides strategic recommendations for the success of market participants. The scope of the study is global. This report estimates market data for 2022 (the base year) and forecasts for 2023 through 2028. Figures for 2023 are estimated, except where actual results have been reported. This report includes forecasts by product type and region from 2023 through 2028.

GI prescriptions have remained one of the largest global therapeutic markets. The global prescription GI therapies market was estimated at $58.7 billion in 2023. This market is expected to reach $87.3 billion by the end of 2028. Rising incidence of GI disorders, such as irritable bowel syndrome (IBS), diarrhea, constipation, inflammatory bowel diseases and gastroesophageal reflux disease (GERD), as well as increasing therapeutic innovations, are key driving factors in the prescription GI therapies market. Growth is also influenced by an increase in the number of gastrointestinal cancers and increased drug prices due to newer, more effective treatments.

The global market for over-the-counter (OTC) GI therapies (e.g., laxatives, antacids, PPIs, H2 inhibitors, anti-diarrheals) was estimated at $17.5 billion in 2023. This market is expected to reach $22.1 billion, growing at a CAGR of 4.8% through 2028. The growth of the OTC therapies market is a multifaceted phenomenon driven by factors ranging from societal trends to regulatory changes and advancements in healthcare. Growing demand in emerging markets is a major driving force for the market.

The global market for GI endoscopy equipment was worth $6.6 billion in 2022. It is estimated to reach $9.8 billion by the end of 2028. The increasing prevalence of GI diseases, such as malignant and benign GI tumors, pancreaticobiliary stones, upper and lower GI bleeding, and pancreatitis, as well as the growing demand for minimally invasive devices for diagnosing and treating these conditions, are the key factors driving the market.

Report Includes

• Analyses of the global market trends, with historical market revenue data (sales figures) from 2020 to 2022, estimates for 2023, forecasts for 2024, and projections of compound annual growth rates (CAGRs) through 2028.
• Discussion of the current and future market potential for GI therapeutics and diagnostics, along with an analysis of the competitive environment, regulatory scenario, and technological advances.
• Estimate of the market size and revenue forecast for the global market, and corresponding market share analysis by diagnostics type, end user and region.
• Facts and figures pertaining to the major market dynamics, opportunities and deterrents, emerging technologies, future prospects and the impacts of macroeconomic variables.
• A look at the GI therapeutics and diagnostic options currently available as well as potential products and classes of products that are likely to have an impact.
• Discussion of sustainability trends and ESG developments, with an emphasis on consumer attitudes, analysis of companies' ESG scores, and the ESG practices followed by leading companies.
• Information pertaining to the recent developments and emerging technologies in the market.
• Review of current and potential treatment options and their impact on this market growth.
• A look at the industry structure, competitive aspects of each product segment, increasing investment in R&D, market development strategies, and company value share analysis.
• An analysis of the competitive landscape based on recent developments and segmental revenues.
• Profiles of the major global players, including Takeda Pharmaceutical Co. Ltd., Johnson & Johnson Services Inc., AbbVie Inc., Sanofi, Bristol-Myers Squibb Co., and F. Hoffmann-La Roche Ltd.

Company Profiles

• Abbvie Inc.
• Bayer Ag
• Boston Scientific Corp.
• Bristol-Myers Squibb Co.
• F. Hoffmann-La Roche Ltd.
• Gsk Plc
• Haleon Group Of Co.
• Johnson & Johnson Services Inc.
• Olympus Corp.
• Procter & Gamble
• Sanofi
• Takeda Pharmaceutical Co. Ltd.

Key Attributes:

Key Topics Covered:

Chapter 1 Executive Summary

• Market Outlook
• Scope of Report
• Highlights of the Global Market for GI Therapeutics and Diagnostics

Chapter 2 Market Overview

• Overview of the Gastrointestinal System
• Physiology of the GI System and the Role of Each Part in the GI Process

Chapter 3 Market Dynamics

• Drivers
• Increasing Prevalence of GI Cancer
• Increasing Prevalence of GI Disorders
• Growing Trend toward Screening and Preventive Care
• Growing Adoption and Approval of Biological Drugs
• High Unmet Need
• Challenges
• Loss of Exclusivity and Genericization
• Regulatory and Safety Issues

Chapter 4 Emerging Technologies and Developments

• Overview
• Incorporation of AI and Other Digital Technologies
• Single-Use Endoscopes
• Focus on Biologics

Chapter 5 Market Segmentation Analysis

• Segmentation Breakdown
• Global Market for Prescription GI Therapeutics, by Drug Type
• Anti-inflammatories for Bowel Diseases
• Gastrointestinal Cancer
• Proton Pump Inhibitors
• Anti-diarrheals
• Others
• Global Market for Prescription GI Drugs, by Type
• Anti-inflammatories for Bowel Diseases
• Gastrointestinal Cancer Therapeutics
• Proton Pump Inhibitors
• Anti-diarrheals
• Others
• Trends in the Market for Prescription GI Drugs
• Global Market for Over-the-Counter GI Drugs, by Drug Type
• Laxatives
• Antacids
• Proton Pump Inhibitors
• Histamine-2 Blockers and Inhibitors
• Anti-diarrheals
• Global Market for Over-the-Counter GI Drugs, by Type
• Laxatives
• Antacids
• Proton Pump Inhibitors
• Histimine-2 Blockers
• Anti-diarrheals
• Opportunities in the Market of Over-the-Counter GI Medications
• Global Market for Gastrointestinal Endoscopy Equipment
• GI Endoscopes and Visualization Systems
• GI Endotherapy Devices
• Global Market for GI Endoscopy Equipment, by Product
• Technological Trends in the Market for GI Endoscopy
• Global Market for GI Endoscopy Equipment, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World
• Opportunities in the Market for GI Endoscopy Equipment
• Global Market for GI Vaccines
• Rotavirus Vaccine
• Hepatitis
• Hepatitis Vaccine
• Global Market for GI Vaccines, by Disease Type
• Global Market for Rotavirus Vaccines, by Region
• Global Market for Hepatitis Vaccines by Region
• Geographic Breakdown
• Global Market for GI Therapeutics and Diagnostics, by Region
• Market Revenue, by Region
• North America
• Europe
• Asia-Pacific
• Rest of the World

Chapter 6 Competitive Intelligence

• Overview
• Over-the-Counter GI Drugs
• Prescription GI Drugs
• GI Endoscopy Equipment
• GI Vaccines
• GI Disease Types
• Disease Types
• Inflammatory Bowel Diseases
• GI Cancer
• Gastroesophageal Reflux Disease

Chapter 7 Appendix

For more information about this report visit https://www.researchandmarkets.com/r/w91cb0

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

View source version on businesswire.com: https://www.businesswire.com/news/home/20240405868475/en/